• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Serine protease 57 (PRSS57)

ACP15985

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP15985 Target NamePRSS57
Target SynonymsPRSS57; PRSSL1; UNQ782/PRO1599Serine protease 57; EC 3.4.21.-; Neutrophil serine protease 4; NSP4; Serine protease 1-like protein 1FormLyophilized powder
Expression SystemCustom Production. Please inquire and provide the desire expression system.Expression Range32-283
Protein LengthFull Length of Mature ProteinPurity>85% (SDS-PAGE)
Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ6UWY2
Background Information
  • Uniprot Id

    Q6UWY2

  • Target Species

    Human

  • Target Name

    PRSS57

  • Target Full Name

    Serine protease 57

  • Target Function

    Serine protease that cleaves preferentially after Arg residues. Can also cleave after citrulline (deimidated arginine) and methylarginine residues.

  • Target Subcellular Location

    Cytoplasmic granule lumen. Secreted.

  • Target Protein Families

    Peptidase S1 family

  • Target Tissue Specificity

    Detected in peripheral blood neutrophil granulocytes, but not in other types of leukocytes. Detected in neutrophils and neutrophil precursors in bone marrow (at protein level). Detected in myeloblasts and promyelocytes in bone marrow.

  • Target Synonyms

    PRSS57; PRSSL1; UNQ782/PRO1599Serine protease 57; EC 3.4.21.-; Neutrophil serine protease 4; NSP4; Serine protease 1-like protein 1

Inquire Recombinant Human Serine protease 57 (PRSS57) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification